| Dr Rebecca G Berke, MD | |
|
Comnavairfor, Box 357051 Nas Ni, San Diego, CA 92135-7051 | |
| (619) 545-1148 | |
| (619) 767-7417 |
| Full Name | Dr Rebecca G Berke |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 23 Years |
| Location | Comnavairfor, San Diego, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083690101 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083A0100X | Preventive Medicine - Aerospace Medicine | 00024886 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Woodland Hills | Woodland hills, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
The Next-Generation Drug Discovery Community will unite researchers at Cambridge University and MIT with partners from the information technology, pharmaceutical and biotechnology industries to find ways to speed up development of the next generation of drugs-particularly those that treat diseases with complex causes such as cancers, arthritis, multiple sclerosis and diabetes.
Lifestyle interventions, including physical activity and structured weight loss programs, can result in significant weight loss for overweight, obese and severely obese adults, according to two reports that were posted online today by JAMA. The studies and accompanying editorials were made available early online to coincide with the presentation of these papers at the 28th Annual Scientific Meeting of the Obesity Society. The articles will appear in the October 27 print issue of JAMA.
A promising new treatment for deadly brain tumors taken orally with minimal side effects is being studied by neurological researchers at Rush University Medical Center, Chicago.
A new commercial venture, using technology developed at Case Western Reserve University's College of Arts and Sciences and Case School of Engineering, has made available avatars-virtual patients-to train speech-language pathologists.
In patients with Parkinson's disease, the antiepileptic drug levetiracetam (Keppra(R)) reduced the involuntary movements (dyskinesia) associated with levodopa, the medication most commonly used to treat Parkinson's disease, according to a study presented today at the 56th annual meeting of the American Academy of Neurology.
› Verified 2 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
The Next-Generation Drug Discovery Community will unite researchers at Cambridge University and MIT with partners from the information technology, pharmaceutical and biotechnology industries to find ways to speed up development of the next generation of drugs-particularly those that treat diseases with complex causes such as cancers, arthritis, multiple sclerosis and diabetes.
Lifestyle interventions, including physical activity and structured weight loss programs, can result in significant weight loss for overweight, obese and severely obese adults, according to two reports that were posted online today by JAMA. The studies and accompanying editorials were made available early online to coincide with the presentation of these papers at the 28th Annual Scientific Meeting of the Obesity Society. The articles will appear in the October 27 print issue of JAMA.
A promising new treatment for deadly brain tumors taken orally with minimal side effects is being studied by neurological researchers at Rush University Medical Center, Chicago.
A new commercial venture, using technology developed at Case Western Reserve University's College of Arts and Sciences and Case School of Engineering, has made available avatars-virtual patients-to train speech-language pathologists.
In patients with Parkinson's disease, the antiepileptic drug levetiracetam (Keppra(R)) reduced the involuntary movements (dyskinesia) associated with levodopa, the medication most commonly used to treat Parkinson's disease, according to a study presented today at the 56th annual meeting of the American Academy of Neurology.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rebecca G Berke, MD 468 Elderberry St, Oak Harbor, WA 98277-9446 Ph: (619) 545-1148 | Dr Rebecca G Berke, MD Comnavairfor, Box 357051 Nas Ni, San Diego, CA 92135-7051 Ph: (619) 545-1148 |
News Archive
The Next-Generation Drug Discovery Community will unite researchers at Cambridge University and MIT with partners from the information technology, pharmaceutical and biotechnology industries to find ways to speed up development of the next generation of drugs-particularly those that treat diseases with complex causes such as cancers, arthritis, multiple sclerosis and diabetes.
Lifestyle interventions, including physical activity and structured weight loss programs, can result in significant weight loss for overweight, obese and severely obese adults, according to two reports that were posted online today by JAMA. The studies and accompanying editorials were made available early online to coincide with the presentation of these papers at the 28th Annual Scientific Meeting of the Obesity Society. The articles will appear in the October 27 print issue of JAMA.
A promising new treatment for deadly brain tumors taken orally with minimal side effects is being studied by neurological researchers at Rush University Medical Center, Chicago.
A new commercial venture, using technology developed at Case Western Reserve University's College of Arts and Sciences and Case School of Engineering, has made available avatars-virtual patients-to train speech-language pathologists.
In patients with Parkinson's disease, the antiepileptic drug levetiracetam (Keppra(R)) reduced the involuntary movements (dyskinesia) associated with levodopa, the medication most commonly used to treat Parkinson's disease, according to a study presented today at the 56th annual meeting of the American Academy of Neurology.
› Verified 2 days ago
Dr. Christine A. Thorne, MD Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 330 Lewis St Ste 400, San Diego, CA 92103 Phone: 619-471-9260 Fax: 619-471-9300 | |
Frederick Y Fung, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 Fir St, San Diego, CA 92101 Phone: 619-446-1510 Fax: 619-446-1514 | |
Dr. Vithya Sairam, M.D Preventive Medicine Medicare: Medicare Enrolled Practice Location: 5575 Ruffin Rd Ste 100, San Diego, CA 92123 Phone: 774-253-5508 | |
Brian C Hoang, PA Preventive Medicine Medicare: Medicare Enrolled Practice Location: 4510 Executive Dr Ste 107, San Diego, CA 92121 Phone: 858-457-4717 | |
Ling Jing, D.O. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 5575 Ruffin Rd, San Diego, CA 92123 Phone: 858-277-2744 Fax: 858-277-3085 | |
Dr. Timothy Wayne O'hara, M.D., M.P.H. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 3235 Albacore Aly, San Diego, CA 92136 Phone: 619-556-7070 |